PDGFRA and central nervous system cancer: In addition, the presence of Telomerase Reverse Transcriptase (TERT) promoter mutations and Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) markers offer valuable additional information regarding the behavior of gliomas and their potential for effective treatment strategies [15].